Stock INBP INTEGRATED BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Integrated BioPharma, Inc.

Equities

INBP

US45811V1052

Market Closed - OTC Markets
Other stock markets
 09:38:40 2024-05-29 EDT 		5-day change 1st Jan Change
0.25 USD -.--% Intraday chart for Integrated BioPharma, Inc. +0.60% +1.96%
05-10 Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
02-12 Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
AQ
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023
CI
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023
CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
CI
INTEGRATED BIOPHARMA INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President
CI
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement
CI
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)
AQ
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
CI
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
INTEGRATED BIOPHARMA INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)
AQ
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022
CI
INTEGRATED BIOPHARMA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
AQ
INTEGRATED BIOPHARMA INC Management's Discussion and Analysis of Financial Condition and Results of Operations (dollars in thousands). (form 10-K)
AQ
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022
CI
INTEGRATED BIOPHARMA INC : Termination of a Material Definitive Agreement (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INBP Stock
  4. News Integrated BioPharma, Inc.